This Phase III multicenter trial will test two different schedules of treatment after surgery for resectable high risk squamous cell carcinoma of the head and neck (H & N): standard radiotherapy or radiochemotherapy (standard RT plus cisplatin). Efficacy measures include evaluation of local control, disease free survival and overall survival. Toxicities of the two regimens will be measured.
Showing the most recent 10 out of 470 publications